We also calculated the proportion of immune cells in the whole DLBCL cohort, accounting for the most, including B cells naive, CD8+ T cells, M2 macrophages, and M0 macrophages (Fig. 5B). This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.